OPENS: Tuesday, July 1, 2014
CLOSES: Tuesday, July 15, 2014
NOTIFICATIONS: Sent by Thursday, July 31, 2014.


The 11th International Conference of the Society for Integrative Oncology (SIO) will be held October 26-28, 2014 in Houston, Texas, USA, hosted by SIO with the assistance of the University of Texas, MD Anderson Cancer Center. The theme is Personalized Integrative Oncology:  Targeted Approaches for Optimal Outcomes.

The 11th International SIO Conference will once again be the gathering place for clinicians, researchers, patients, advocates and trainees in integrative cancer care from all over the world. The SIO Conference will provide an opportunity for attendees to hear about advancements made in the field, present their research findings, build collaborations, and learn from each other.

Our schedule includes keynotes, plenary sessions, moderated panels, multidisciplinary tumor boards, experiential workshops, and oral and poster presentations of research findings. There will be informal time for gathering, including a Sunday night poster session and reception and a Monday night dinner. Visit the conference website  for more information.

Abstracts for oral and poster presentations that represent the broad spectrum of integrative cancer research (basic, clinical, health care utilization, cost effectiveness, program and best practice guideline development) and clinical care are welcomed. In keeping with the conference theme, individuals submitting abstracts are encouraged to consider the targeted and personalized approaches of their work and its relevance to integrative cancer care.

Members of the Abstract Review Committee will evaluate the quality of the submitted abstracts on the basis of the following criteria: 1) novelty of the research, 2) significance of the findings, 3) clarity, and 4) relevance to the conference theme. Authors should be particularly cognizant of the importance of setting forth the objectives and hypotheses/research questions of the study in a clear, succinct manner and of summarizing the results (if applicable). If the abstract is poorly written, such that the Abstract Review Committee cannot determine its novelty and importance, the abstract will not be accepted for presentation at the Conference.

The abstract should comply with the ethics of scholarly activities in general and should be free of commercial bias. The authors must disclose conflicts of interest as required by continuing education accreditation bodies.

Authors must indicate whether the abstract material has been presented at other scientific meetings. Abstracts previously presented at another scientific meeting are eligible to be selected for poster or oral presentation, but are not eligible for the "Best of SIO" designation. If the research has been accepted for publication or has been recently published, it is the author's responsibility to comply with the journalcopyright rules.

An Abstract Submission Number will be assigned to each abstract. This number will be displayed at the top of the submitter screen and will be listed on all e-mail correspondence regarding the abstract. Please refer to the Abstract Submission Number in any subsequent abstract communications.

Authors are strongly encouraged to print a copy of their abstracts for their records before submitting. At the time of submission, an email will be sent to the corresponding author at the address provided in the SIO Abstract Submission System. Notifications of abstract status will be sent by the end of June 2014. Once an abstract has been submitted, it may be edited or withdrawn via the SIO Abstract Submission System using the Abstract Submission Number and the password that was supplied at the time of submission.

The accuracy of the submitted abstract is the responsibility of the authors. Although abstracts will be typeset for print and electronic distribution, they will not be edited for typographical errors or corrected by SIO staff except as needed to conform to publication style. Therefore, authors should carefully prepare and proofread their abstracts prior to submission.

If you have completed an abstract submission, you may log in and edit the abstract as often as you wish until the submission deadline. However, once abstract submission is closed, no additional changes will be accepted.

For event information, visit the conference website.
For all technical questions, please contact the Abstract Administrator:
For all policy questions, please contact the Abstract Review Committee Chair:


  1. Research abstracts should contain
    1. Background: an introductory sentence indicating the purpose(s) of the study;
    2. Methods: a brief description of pertinent methodological procedures;
    3. Results: a summary of the findings; and
    4. Conclusion: a statement of the conclusions based on the results.
  2. Non-research abstracts (e.g., program description, methodological issues) should contain
    1. An introductory sentence describing the purpose of the presentation;
    2. A brief description of main concepts; and
    3. A statement of conclusion(s).
  3. Authors must accept sole responsibility for the statements in their abstracts. Abstracts should be carefully proofread to avoid errors in the published literature.
  4. Abstracts must be submitted in English and follow the instruction of American Spelling that is described in Scientific Style and Format: The CSE Manual for Authors, Editors, and Publishers, Seventh Edition (Council of Science Editors, 2006).
  5. Abstracts must be submitted in a Microsoft Word file, single-spaced, using font name Arial and font size 12.
  6. Abstracts  should not contain any citations.
  7. Abstracts should not exceed 300 words.
  8. All communication will be with the primary author  only.
  9. The format should be:
    2. Single space
    3. List of authors with their affiliations, city, province/state, and country (i.e. Department of General Oncology, The University of Texas, MD Anderson Cancer Center, Houston, TX, USA) in one paragraph separated by commas. Place an asterisk (*) after the name of primary author.
    4. Single space
    5. Abstract


ABSTRACT TITLE (CAPS, Arial, 14pt, Bold, Centered)
C.D. Author1; E.F. Collaborator1,2; G.H. Coauthor2  (Arial, 12pt)
1Department of Anatomy and 2Department of Oncology, University of British Columbia,
Vancouver, BC, Canada (Arial,10pt)

BACKGROUND: (CAPS, Arial, 12pt, Bold, Left Justified)

Briefly describe the purpose of the study in this section. The key is to be clear and concise. The required information can be provided in several sentences that guide the reader and provide a framework for the study. (Arial, 12pt, Left Justified)

METHODS: (CAPS, Arial, 12pt, Bold, Left Justified)

The methods are briefly described in this section. Again only one or two sentences should be used to describe the methods used in general terms. (Arial, 12pt, Left Justified)

RESULTS:  (CAPS, Arial, 12pt, Bold, Left Justified)

The results section should provide a clearly organized report of the data collected during the study. Ensure the correct units are used with numerical data, and provide statistical significance where possible. Any representation of the data is possible, including graphical or tabular data. Images may also be used, but in general the number of characters used in the abstract should be reduced accordingly if images, tables or graphs occupy space within the abstract. Please note that all graphs or images count as four words. (Arial, 12pt, Left Justified)

CONCLUSIONS: (CAPS, Arial, 12pt, Bold, Left Justified)

Draw conclusions and relay the significance of the results in this section; only one or two concise sentences are required. (Arial, 12pt, Left Justified)


**Please ensure title, authors, and affiliations are centered;
all other text should be left justified**


SIO has the right to review and select abstracts at its discretion for oral or poster presentation.




Enter your email & password
to access your account.




Reset Password


Conference Management Software by X-CD Technologies Inc.